rosiglitazone has been researched along with Candidiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auwerx, J; Bernad, J; Burcelin, R; Coste, A; Galès, A; Lefèvre, L; Olagnier, D; Perez, L; Pipy, B; Valentin, A | 1 |
| Arnal, JF; Authier, H; Auwerx, J; Balard, P; Bernad, J; Coste, A; Douin-Echinard, V; Filipe, C; Galès, A; Lagane, C; Lepert, JC; Linas, MD; Pipy, B | 1 |
2 other study(ies) available for rosiglitazone and Candidiasis
| Article | Year |
|---|---|
PPARγ ligands switched high fat diet-induced macrophage M2b polarization toward M2a thereby improving intestinal Candida elimination.
Topics: Animals; Candida albicans; Candidiasis; Diabetes Mellitus, Type 2; Dietary Fats; Humans; Intestines; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2010 |
IL-13 attenuates gastrointestinal candidiasis in normal and immunodeficient RAG-2(-/-) mice via peroxisome proliferator-activated receptor-gamma activation.
Topics: Animals; Candida albicans; Candidiasis; Cecum; Cell Movement; DNA-Binding Proteins; Female; Gastrointestinal Diseases; Immunologic Deficiency Syndromes; Interleukin-13; Lectins, C-Type; Ligands; Macrophages; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Knockout; PPAR gamma; Receptors, Cell Surface; Rosiglitazone; Thiazolidinediones | 2008 |